Evidence map›Paper›PMID 37743411›Full record

ArticleSignal transduction and targeted therapy2023

Secreted LRPAP1 binds and triggers IFNAR1 degradation to facilitate virus evasion from cellular innate immunity.

Huangcan Li, Xiong Wang, Yiran Wang, Yichen Li, Ying Chen, Yin-Ting Wong, Jufang He, Ming-Liang He

Open access · goldAbstract read
In one paragraph

Article in Signal transduction and targeted therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Carbon Quantum Dots Assisted Virus Tracking: From Skin to Brain.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Huangcan Li *Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.ORCID http://orcid.org/0000-0003-1409-9219
Xiong Wang *Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
Yiran Wang *Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
Yichen LiDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
Ying ChenDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
Yin-Ting WongDepartment of Neurosciences, City University of Hong Kong, Hong Kong, China.
Jufang HeDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
Ming-Liang HeDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong, China. minglihe@cityu.edu.hk.
City University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The crucial role of interferon (IFN) signaling is well known in the restriction or eradication of pathogen invasion. Viruses take a variety of ways to antagonize host defense through eliminating IFN-signaling intracellularly for decades. However, the way by viruses target IFN-signaling extracellularly has not been discovered. Infection by both coronavirus SARS-CoV-2 and enterovirus 71 (EV71 or EV-A71) can cause severe diseases such as neurological disorders and even death in children.

Indexed as

COVID-19AnimalsAntiviral AgentsChildHumansImmunity, InnateMiceReceptor, Interferon alpha-betaSARS-CoV-2Signal TransductionAntiviral AgentsIFNAR1 protein, humanReceptor, Interferon alpha-beta

Identifiers

PMID37743411
PMCPMC10518340
OpenAlexW4386998997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.